- Home
- Equipment
- usa california
- prostate tumors
Show results for
Refine by
Prostate Tumors Equipment Supplied In Usa California
13 equipment items found
Manufactured by:Intramedical Imaging, LLC based inHawthorne, CALIFORNIA (USA)
Available Tip Sizes: 5mm, 10mm; Node Biopsy/Mapping in Cervical, Prostate and Gastric ...
by:Antech Diagnostics based inFountain Valley, CALIFORNIA (USA)
Antech’s molecular diagnostics use and develop novel technologies that enable faster and more personalized diagnoses. With tests such as CADET® BRAF/PLUS and comprehensive PCR panels, we are the innovative leader in molecular research and testing. ...
Manufactured by:Ardigen based inKraków, POLAND
Accelerated learning to reveal more from your biopsy results; Our platform enables you to process whole-slide biopsy images in a scalable manner, without any loss of information contained in the image and with instant quality check and image standardization. Moreover, it highlights areas that contain pathological changes and performs automatic segmentation of the tissue. This process can be ...
Manufactured by:Pathnostics based inIrvine, CALIFORNIA (USA)
Prostate biopsies are performed when results from initial tests, like a prostate-specific antigen (PSA) blood test or digital rectal exam, indicate the possibility of prostate cancer. A range of tissue samples are extracted with a needle from the prostate gland and are analyzed under a microscope to identify cancerous cell abnormalities. If cancer is present, it can be localized to the exact ...
Manufactured by:Veracyte, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Providing clarity and confidence in treatment planning. The Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) genomic classifier is a 22-gene, whole-transcriptome-developed test designed to help inform treatment decisions for men with localized prostate cancer at initial diagnosis and after surgical removal of the prostate. The test reports the Decipher Score, which ...
Manufactured by:Xoft, Inc. based inSan Jose, CALIFORNIA (USA)
The versatile Xoft Axxent Electronic Brachytherapy (eBx) System utilizes state-of-the-art 50kV x-ray technology to provide expanded treatment options for a range of cancers. The Xoft System provides isotope-free HDR therapeutic radiation of the disease target while sparing surrounding healthy ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of metastasis-specific biomarkers in patient urine sample or biopsy tissue sample to detect existing metastatic prostate cancer and predict prostate cancer that will become metastatic in the ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer-specific biomarkers in patient urine sample or biopsy tissue sample to distinguish prostate cancer from benign patients or normal ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. “Rule-out” otherwise cancer-free men from undergoing unnecessary ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...
Manufactured by:Qualigen Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
Qualigen licensed the G4 selective transcription inhibitor platform from University College London (UCL) in 2022. The licensed technology comprises lead compound QN-302 (formerly SOP1812) and back-up compounds that target regulatory regions of cancer genes that down-regulate gene expression in multiple cancer pathways. Developed by Dr. Stephen Neidle and his group at UCL, the G4 binding concept ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive prostate cancer needing immediate treatment from low-risk and indolent prostate cancer needing only ...